MedTech News
Synchrony Medical Receives 510(k) FDA Clearance for LibAirty™ Airway Clearance System for At-Home Respiratory Relief
JERSEY CITY, N.J. and OR YEHUDA, Israel, July 10, 2025 /PRNewswire/ — Synchrony Medical, a medical technology company dedicated to advancing respiratory care, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its LibAirty™ Airway Clearance System in the United States.
Dymicron Granted IDE Approval for Triadyme-C Artificial Disc
OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to begin a pivotal clinical study of the Triadyme®–C cervical artificial disc.
Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials.
Substances isolated from marine sponges show potential for treating malaria
Brazilian researchers have discovered chemical compounds in marine sponges that have the potential to eliminate the malaria parasite, including strains that are resistant to conventional antimalarial drugs. The research results were published in the journal ACS Infectious Diseases.
AI-enhanced echocardiography improves early detection of amyloid buildup in the heart
An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, England, is highly accurate in screening for cardiac amyloidosis, a rare and progressive type of heart failure, according to a new study. The model is the first and only AI tool of its kind.
Skin-like sensor can track body movement and electrical signals inside and out
A new skin-like sensor developed by an international team led by researchers at Penn State could help doctors monitor vital signs more accurately, track healing after surgery and even help patients with bladder control issues.
Real-time trial shows AI could speed cancer care
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how doctors determine the best treatment for cancer patients—by enhancing how tumor samples are analyzed in the lab.
Novel AI method sheds light on how enzyme linked to Alzheimer’s selects its targets
Researchers from DZNE, Ludwig-Maximilians-Universität München (LMU), and Technical University of Munich (TUM) have found that the enzyme “gamma-secretase”—implicated in Alzheimer’s disease and cancer—selects its reaction partners according to a complex scheme of molecular features.